Nephrotic syndrome after treatment with 5-aminosalicylic acid
about
Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.Sulphasalazine induced renal failureNephrotic syndrome associated with sulphasalazineMinimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylateDisposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretionTests of renal function in patients with quiescent colitis: effects of drug treatment.Drug therapy of ulcerative colitis5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.Sulphasalazine in ulcerative colitis: in memoriam?Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review.Do gastroenterologists monitor their patients taking 5-amino-salicylates following initiation of treatmentWhat dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?Mesalazine induced interstitial nephritis.Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin.Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis.Steady-state pharmacokinetics of a new 4-gram 5-aminosalicylic acid retention enema in patients with ulcerative colitis in remission.
P2860
Q28319792-DE8A2AF6-0CEF-4A30-8DA7-01E6188CA972Q28327625-4B76AE48-51D0-460F-B554-00890081DA91Q28334366-C9036C74-2FF1-4085-BD8E-44DD89BC32A8Q32026628-ADB0850A-6D96-4BB6-84AB-13A95144EA82Q33618202-EB037FA4-7AB6-4F12-A132-BB5A5677100AQ34393049-8DC48E3E-50B2-4D39-9399-7C1E0EA5A98AQ34396529-05A3720C-BC97-4E33-B765-09ADB4676355Q34403155-F37F09BD-6C19-4B83-89A7-02E406BC4297Q36002369-0BFD2ED6-3FF4-4D87-AAEF-03B11407AECDQ36495618-45B76BAD-B33E-4415-891B-F921FAB2D363Q38064863-94ADA683-064C-439F-8A38-5DC14940F892Q38609002-92EA8FE0-8723-429A-890B-C8F8847325ABQ41903886-8C1EF894-0E4F-441E-880D-5A2F8331FFCBQ43214172-C0304E85-5258-4503-AF57-F90621C1CFAFQ43892494-66C4D9C9-C816-4C26-AC3C-3096629FB08BQ44538896-46A2D42F-0BC5-4374-97CE-69CE9EE1BB7DQ45917894-0AA350F3-161A-43C6-9E25-5D7A494E261FQ54306195-C88F5545-B838-4378-8D49-B2DAFE23EF6E
P2860
Nephrotic syndrome after treatment with 5-aminosalicylic acid
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@ast
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@en
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@nl
type
label
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@ast
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@en
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@nl
prefLabel
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@ast
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@en
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@nl
P2093
P1433
P1476
Nephrotic syndrome after treatment with 5-aminosalicylic acid
@en
P2093
P2860
P356
10.1136/BMJ.296.6634.1442
P407
P577
1988-05-21T00:00:00Z